Published in J Infect Dis on February 01, 1975
Dissemination of an antibiotic resistance plasmid in hospital patient flora. Antimicrob Agents Chemother (1980) 1.79
Integrated Multilevel Surveillance of the World's Infecting Microbes and Their Resistance to Antimicrobial Agents. Clin Microbiol Rev (2011) 1.44
A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother (1995) 26.51
Microbial complexes in subgingival plaque. J Clin Periodontol (1998) 15.90
The introduction of jet injection mass vaccination into the national smallpox eradication program of Brazil. Trop Geogr Med (1971) 11.37
More extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1991) 11.28
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother (1990) 6.11
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother (1990) 5.81
Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother (1997) 4.20
Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin. J Infect Dis (1971) 3.76
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol (1994) 3.61
Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother (1996) 3.44
Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet (1975) 3.34
Five novel plasmid-determined beta-lactamases. Antimicrob Agents Chemother (1985) 3.34
Vacuum blood-culture bottles inhibiting growth of Candida and fostering growth of Bacteroides. Lancet (1974) 3.26
Comparison of polyacrylamide and agarose gel thin-layer isoelectric focusing for the characterization of beta-lactamases. Antimicrob Agents Chemother (1983) 3.19
Molecular cloning and DNA homology of plasmid-mediated beta-lactamase genes. Mol Gen Genet (1987) 3.12
Molecular epidemiology of antibiotic resistance in salmonella from animals and human beings in the United States. N Engl J Med (1982) 2.97
Beta-lactamases. Br Med Bull (1984) 2.90
Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation (1992) 2.88
Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet (1981) 2.41
The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med (1990) 2.40
Microbiota of health, gingivitis, and initial periodontitis. J Clin Periodontol (1998) 2.35
The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med (1978) 2.29
Spread of a "Pseudomonas-specific" beta-lactamase to plasmids of enterobacteria. J Bacteriol (1982) 2.28
An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b. Antimicrob Agents Chemother (1986) 2.21
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains. Antimicrob Agents Chemother (2000) 2.15
Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol (1999) 2.14
Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother (1992) 2.07
Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J Clin Periodontol (1998) 2.06
Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol (1987) 2.02
Cultivable anaerobic microbiota of severe early childhood caries. J Clin Microbiol (2011) 1.85
Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy. Antimicrob Agents Chemother (1981) 1.81
Dissemination of an antibiotic resistance plasmid in hospital patient flora. Antimicrob Agents Chemother (1980) 1.79
Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance. Diagn Microbiol Infect Dis (1992) 1.74
Broad-spectrum, transmissible beta-lactamases. N Engl J Med (1988) 1.70
Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection. Antimicrob Agents Chemother (1994) 1.70
Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis (1997) 1.61
Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy. J Infect Dis (1987) 1.60
Computer-generated plots of results of antimicrobial-susceptibility tests. JAMA (1969) 1.58
Gingival recession: intra-oral distribution and associated factors. J Periodontol (1994) 1.55
Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol (1995) 1.55
Evidence for cigarette smoking as a major risk factor for periodontitis. J Periodontol (1993) 1.53
The effect of SRP on the clinical and microbiological parameters of periodontal diseases. J Clin Periodontol (1997) 1.50
Recent experience with bacillemia due to gram-negative organisms. J Infect Dis (1971) 1.50
Genetic and biochemical properties of AER-1, a novel carbenicillin-hydrolyzing beta-lactamase from Aeromonas hydrophila. Antimicrob Agents Chemother (1985) 1.45
Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis (1993) 1.44
Intercontinental spread of a new antibiotic resistance gene on an epidemic plasmid. Science (1985) 1.43
The Holy Cross college football team hepatitis outbreak. JAMA (1972) 1.42
Diagnosis of gonorrhea in male patients by culture of uncentrifuged first-voided urine. JAMA (1977) 1.42
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. Antimicrob Agents Chemother (1993) 1.39
Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC. Antimicrob Agents Chemother (1996) 1.39
Novel plasmid-mediated beta-lactamase in members of the family Enterobacteriaceae from Ohio. Antimicrob Agents Chemother (1986) 1.38
Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay. Antimicrob Agents Chemother (1990) 1.36
International comparison of prevalence of resistance to antibiotics. JAMA (1978) 1.34
The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results. J Clin Periodontol (2000) 1.32
Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae. J Infect Dis (1976) 1.27
Single-disk diffusion testing (Kirby-Bauer) of susceptibility of Proteus mirabilis to chloramphenicol: significance of the intermediate category. J Clin Microbiol (1980) 1.24
Role of microtubules in contractile dysfunction of hypertrophied cardiocytes. Circulation (1994) 1.23
Characterization of the beta-lactamases of six species of Legionella. J Bacteriol (1982) 1.20
Automated use of WHONET and SaTScan to detect outbreaks of Shigella spp. using antimicrobial resistance phenotypes. Epidemiol Infect (2009) 1.19
Resistance of bacteria to antibacterial agents: report of Task Force 2. Rev Infect Dis (1987) 1.18
Gly-238-Ser substitution changes the substrate specificity of the SHV class A beta-lactamases. Proteins (1991) 1.17
IS6770, an enterococcal insertion-like sequence useful for determining the clonal relationship of clinical enterococcal isolates. J Infect Dis (1994) 1.17
Induction of beta-lactamase and methicillin resistance in unusual strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1990) 1.17
Microbiota of severe early childhood caries before and after therapy. J Dent Res (2011) 1.16
Molecular epidemiology of OHIO-1 beta-lactamase. Antimicrob Agents Chemother (1987) 1.14
Kinetics of enamel demineralization in vitro. J Dent Res (1999) 1.13
Trimethoprim resistance in multiple genera of Enterobacteriaceae at a U.S. hospital: spread of the type II dihydrofolate reductase gene by a single plasmid. J Infect Dis (1985) 1.13
A colorimetric procedure for measuring beta-lactamase activity. Anal Biochem (1988) 1.11
Beta-lactamase effect on ampicillin treatment of Haemophilus influenzae B bacteremia and meningitis in infant rats. Antimicrob Agents Chemother (1977) 1.11
Bacterial infection in renal homotransplant recipients. A study of fifty-three bacteremic episodes. Am J Med (1972) 1.11
Role of beta-lactamase in expression of resistance by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1987) 1.11
DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol (1995) 1.10
Global surveillance of antibiotic resistance. N Engl J Med (1992) 1.09
Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation. Circ Res (1989) 1.09
Antibiotic resistance. Epidemiology and therapeutics. Diagn Microbiol Infect Dis (1992) 1.09
Resistance to antibiotics at medical centres in different parts of the world. J Antimicrob Chemother (1986) 1.08
A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J Infect Dis (1990) 1.08
Listeroisis in immunosuppressed patients. A cluster of eight cases. Am J Med (1975) 1.08
Clinical risk indicators for periodontal attachment loss. J Clin Periodontol (1991) 1.06
Implications of antimicrobial resistance in the empirical treatment of community-acquired respiratory tract infections: the case of macrolides. J Antimicrob Chemother (2002) 1.05
Nosocomial outbreaks of multiresistant bacteria: extended-spectrum beta-lactamases have arrived in North America. Ann Intern Med (1993) 1.04
Phycomycotic gangrenous cellulitis. A report of two cases and a review of the literature. Arch Surg (1976) 1.03
Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. J Clin Periodontol (1995) 1.03
Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation. Circ Res (1992) 1.02